The Patient-Centered Outcomes Research Institute plans to award $4.75 million to compare ways to raise COVID-19 immunization rates
Drs. Greg Simon and Megan Gary share how new processes improved suicide risk identification when mental health visits went virtual.
NIAID-sponsored study includes Seattle in test for benefits of mixing different vaccine types.
An investigational vaccine developed by Moderna is being tested for safety and immune response in Seattle and 3 other cities.
New study calculates risk-based approach to detect the most cancers with the fewest exams.
Lisa Jackson, MD, MPH, Kaiser Permanente Washington senior investigator, recounts the genesis of a groundbreaking vaccine.
Dr. Sascha Dublin tells how studies of KP electronic health record data can improve COVID-19 treatment and prevention.
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.